MEDICAMEQ.NS
Price:
$377.45
Market Cap:
$5.12B
Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-10-27
Stock Exchange
NSE
Ticker
MEDICAMEQ.NS
According to Medicamen Biotech Limited’s latest financial reports and current stock price. The company's current PE Ratio is 54.39. This represents a change of -29.86% compared to the average of 77.55 of the last 4 quarters.
The mean historical PE Ratio of Medicamen Biotech Limited over the last ten years is 171.32. The current 54.39 PE Ratio has changed 3.07% with respect to the historical average. Over the past ten years (40 quarters), MEDICAMEQ.NS's PE Ratio was at its highest in in the September 2015 quarter at 353.85. The PE Ratio was at its lowest in in the December 2015 quarter at -93.88.
Average
171.32
Median
55.44
Minimum
46.17
Maximum
1.14K
Discovering the peaks and valleys of Medicamen Biotech Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.04%
Maximum Annual PE Ratio = 1.14K
Minimum Annual Increase = -90.20%
Minimum Annual PE Ratio = 46.17
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 88.21 | 91.04% |
| 2024 | 46.17 | -16.49% |
| 2023 | 55.29 | 5.21% |
| 2022 | 52.55 | -5.48% |
| 2021 | 55.60 | 9.58% |
| 2020 | 50.74 | -5.51% |
| 2019 | 53.70 | -12.16% |
| 2018 | 61.13 | -45.18% |
| 2017 | 111.52 | -90.20% |
| 2016 | 1.14K | 0.61% |
The current PE Ratio of Medicamen Biotech Limited (MEDICAMEQ.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
63.22
5-year avg
59.56
10-year avg
171.32
Medicamen Biotech Limited’s PE Ratio is less than Albert David Limited (70.69), greater than Medico Remedies Limited (42.56), greater than Medico Remedies Limited (42.56), greater than Kilitch Drugs (India) Limited (19.76), greater than Venus Remedies Limited (18.67), greater than Venus Remedies Limited (18.67), greater than ZIM Laboratories Limited (37.36), greater than Bafna Pharmaceuticals Limited (41.05), greater than Kilitch Drugs (India) Limited (19.76), greater than ZIM Laboratories Limited (37.36),
| Company | PE Ratio | Market cap |
|---|---|---|
| 70.69 | $4.45B | |
| 42.56 | $4.55B | |
| 42.56 | $4.42B | |
| 19.76 | $5.57B | |
| 18.67 | $10.02B | |
| 18.67 | $10.03B | |
| 37.36 | $3.39B | |
| 41.05 | $3.39B | |
| 19.76 | $5.88B | |
| 37.36 | $3.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medicamen Biotech Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medicamen Biotech Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Medicamen Biotech Limited's PE Ratio?
How is the PE Ratio calculated for Medicamen Biotech Limited (MEDICAMEQ.NS)?
What is the highest PE Ratio for Medicamen Biotech Limited (MEDICAMEQ.NS)?
What is the 3-year average PE Ratio for Medicamen Biotech Limited (MEDICAMEQ.NS)?
What is the 5-year average PE Ratio for Medicamen Biotech Limited (MEDICAMEQ.NS)?
How does the current PE Ratio for Medicamen Biotech Limited (MEDICAMEQ.NS) compare to its historical average?